,
Reading, Stephanie R.
Black, Mary Helen
Singer, Daniel E.
Go, Alan S.
Fang, Margaret C.
Udaltsova, Natalia
Harrison, Teresa N.
Wei, Rong X.
Liu, In-Lu Amy
Reynolds, Kristi https://orcid.org/0000-0001-7619-1649
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (RC2HL101589)
Article History
Received: 11 October 2018
Accepted: 4 February 2019
First Online: 11 February 2019
Ethics approval and consent to participate
: This study was approved by the ethics committees at Kaiser Permanente Northern and Southern California (reference numbers CN-09AGo-14-H and 5572, respectively). A waiver of written informed consent was obtained due to the nature of the study being a minimal-risk health questionnaire.
: Not applicable.
: Stephanie R. Reading: Current employment at Amgen Inc.Mary Helen Black: Current employment at Ambry Genetics.Daniel E. Singer: Partial support by the Eliot B. and Edith C. Shoolman Fund of Massachusetts General Hospital, Boston, MA; Consultant/advisory board role with Boehringer Ingelheim, Bristol-Myers Squibb, CVS Health, Johnson and Johnson, Merck and Pfizer; Research funding from Bristol-Myers Squibb and Boehringer Ingelheim.Alan S. Go: Received research funding from the National Heart, Lung and Blood Institute; the National Institute of Diabetes, Digestive and Kidney Diseases; the National Institute on Aging and iRhythm Technologies.Kristi Reynolds: Received research funding from iRhythm Technologies.Margaret C. Fang, Natalia Udaltsova, Teresa N. Harrison, Rong Wei, In-Lu Amy Liu: No disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.